Comparison of 99mTc-MIBI SPECT/1818F-FDG PET imaging and cardiac magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy: Assessment of cardiac function and myocardial injury

Clinical Nuclear Medicine

Volumn 37, Issue 12, 2012, Pages 1163-1169

  Wang, Lei ^a   Yan, Chaowu ^a   Zhao, Shihua ^a   Fang, Wei ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

cardiac function; cardiac magnetic resonance imaging; idiopathic dilated cardiomyopathy; myocardial injury; positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM; GADOLINIUM PENTETATE MEGLUMINE; TECHNETIUM 99M; CONTRAST MEDIUM; DIAGNOSTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE INJURY; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; COMPARATIVE STUDY; CORONARY ARTERY BLOOD FLOW; DIAGNOSTIC IMAGING; HEART; HEART INJURY; HEART LEFT VENTRICLE FUNCTION; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; SCINTISCANNING;

CARDIOMYOPATHY, DILATED; CONTRAST MEDIA; CORONARY CIRCULATION; DIAGNOSTIC IMAGING; FEMALE; FLUORODEOXYGLUCOSE F18; GADOLINIUM; HEART; HEART INJURIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT; YOUNG ADULT;

EID: 84870178506     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3182708794     Document Type: Article

References (46)

1. Fatkin D, Otway R, Richmond Z. Genetics of dilated cardiomyopathy. Heart Fail Clin. 2010;6:129-140.
2. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med. 1994; 331:1564-1575.
3. Jefferies JL, Towbin JA. Dilated cardiomyopathy. Lancet. 2010;375:752-762.
4. Neglia D, L'Abbate A. Coronary microvascular dysfunction and idiopathic dilated cardiomyopathy. Pharmacol Rep. 2005; 57:151-155.
5. West AM, Kramer CM. Cardiovascular magnetic resonance imaging of myocardial infarction, viability, and cardiomyopathies. Curr Probl Cardiol. 2010; 35:176-220.
6. de Jong RM, Tio RA, van der Harst P, et al. Ischemic patterns assessed by positron emission tomography predict adverse outcome in patients with idiopathic dilated cardiomyopathy. J Nucl Cardiol. 2009;16:769-774.
7. Ono H, Funabashi N, Uehara M, et al. Comprehensive evaluation of characteristics of left ventricular myocardium in a subject with non-coronary arterial cardiac dysfunction through segment by segment analysis using various diagnostic modalities. Int J Cardiol. 2010;145:95-100.
8. Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113:1807-1816.
9. Wang F, Zhang J, Fang W, et al. Evaluation of left ventricular volumes and ejection fraction by gated SPECT and cardiac MRI in patients with dilated cardiomyopathy. Eur J Nucl Med Mol Imaging. 2009;36:1611-1621.
10. Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol. 2006;48: 1977-1985.
11. Dulce MC, Mostbeck GH, Friese KK, et al. Quantification of the left ventricular volumes and function with cine MR imaging: comparison of geometric models with three-dimensional data. Radiology. 1993;188:371-376.
12. Hofman HA, Knaapen P, Boellaard R, et al. Measurement of left ventricular volumes and function with O-15-labeled carbon monoxide gated positron emission tomography: comparison with magnetic resonance imaging. J Nucl Cardiol. 2005;12:639-644.
13. Bavelaar-Croon CD, Kayser HW, van der Wall EE, et al. Left ventricular function: correlation of quantitative gated SPECT and MR imaging over a wide range of values. Radiology. 2000;217:572-575.
14. Bax JJ, Lamb H, Dibbets P, et al. Comparison of gated single-photon emission computed tomography with magnetic resonance imaging for evaluation of left ventricular function in ischemic cardiomyopathy. Am J Cardiol. 2000;86: 1299-1305.
15. Tadamura E, Kudoh T, Motooka M, et al. Assessment of regional and global left ventricular function by reinjection T1-201 and rest Tc-99m sestamibi ECG-gated SPECT: comparison with three-dimensional magnetic resonance imaging. J Am Coll Cardiol. 1999;33:991-997.
16. Tadamura E, Kudoh T, Motooka M, et al. Use of technetium-99m sestamibi ECG-gated single-photon emission tomography for the evaluation of left ventricular function following coronary artery bypass graft: comparison with three-dimensional magnetic resonance imaging. Eur J Nucl Med. 1999;26: 705-712.
17. Thorley PJ, Plein S, Bloomer TN, et al. Comparison of 99mTc tetrofosmin gated SPECT measurements of left ventricular volumes and ejection fraction with MRI over a wide range of values. Nucl Med Commun. 2003;24:763-769.
18. Lipke CS, Kuhl HP, Nowak B, et al. Validation of 4D-MSPECT and QGS for quantification of left ventricular volumes and ejection fraction from gated 99mTc-MIBI SPET: comparison with cardiac magnetic resonance imaging. Eur J Nucl Med Mol Imaging. 2004;31:482-490.
19. Persson E, Carlsson M, Palmer J, et al. Evaluation of left ventricular volumes and ejection fraction by automated gated myocardial SPECT versus cardiovascular magnetic resonance. Clin Physiol Funct Imaging. 2005;25:135-141.
20. Rajappan K, Livieratos L, Camici PG, et al. Measurement of ventricular volumes and function: a comparison of gated PET and cardiovascular magnetic resonance. J Nucl Med. 2002;43:806-810.
21. Schaefer WM, Lipke CS, Nowak B, et al. Validation of an evaluation routine for left ventricular volumes, ejection fraction and wall motion from gated cardiac FDG PET: a comparison with cardiac magnetic resonance imaging. Eur J Nucl Med Mol Imaging. 2003;30:545-553.
22. Schaefer WM, Lipke CS, Nowak B, et al. Validation of QGS and 4D-MSPECT for quantification of left ventricular volumes and ejection fraction from gated 18F-FDG PET: comparison with cardiac MRI. J Nucl Med. 2004;45:74-79.
23. Slart RH, Bax JJ, de Jong RM, et al. Comparison of gated PET with MRI for evaluation of left ventricular function in patients with coronary artery disease. J Nucl Med. 2004;45:176-182.
24. Mistry N, Halvorsen S, Hoffmann P, et al. Assessment of left ventricular function with magnetic resonance imaging vs. echocardiography, contrast echocardiography, and single-photon emission computed tomography in patients with recent ST-elevation myocardial infarction. Eur J Echocardiogr. 2010;11:793-800.
25. Sipola P, Peuhkurinen K, Vanninen E. Comparison of gated single-photon emission computed tomography with magnetic resonance imaging for evaluation of left ventricular volumes and ejection fraction in patients with idiopathic dilated cardiomyopathy. Int J Cardiovasc Imaging. 2011;27:629-634.
26. Faber TL, Vansant JP, Pettigrew RI, et al. Evaluation of left ventricular endocardial volumes and ejection fractions computed from gated perfusion SPECT with magnetic resonance imaging: comparison of two methods. J Nucl Cardiol. 2001;8:645-651.
27. Schaefer WM, Lipke CS, Standke D, et al. Quantification of left ventricular volumes and ejection fraction from gated 99mTc-MIBI SPECT: MRI validation and comparison of the Emory Cardiac Tool Box with QGS and 4DMSPECT. J Nucl Med. 2005;46:1256-1263.
28. Stegger L, Lipke CS, Kies P, et al. Quantification of left ventricular volumes and ejection fraction from gated 99mTc-MIBI SPECT: validation of an elastic surface model approach in comparison to cardiac magnetic resonance imaging, 4D-MSPECT and QGS. Eur J Nucl Med Mol Imaging. 2007;34:900-909.
29. Wu KC, Weiss RG, Thiemann DR, et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol. 2008;51:2414-2421.
30. Vohringer M, Mahrholdt H, Yilmaz A, et al. Significance of late gadolinium enhancement in cardiovascular magnetic resonance imaging (CMR). Herz. 2007;32:129-137.
31. De Cobelli F, Pieroni M, Esposito A, et al. Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. J Am Coll Cardiol. 2006;47: 1649-1654.
32. Unverferth DV, Magorien RD, Lewis RP, et al. The role of subendocardial ischemia in perpetuating myocardial failure in patients with nonischemic congestive cardiomyopathy. Am Heart J. 1983;105:176-179.
33. van den Heuvel AF, van Veldhuisen DJ, van der Wall EE, et al. Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2000;35:19-28.
34. Neglia D, Sambuceti G, Iozzo P, et al. Myocardial metabolic and receptor imaging in idiopathic dilated cardiomyopathy. Eur J Nucl Med Mol Imaging. 2002;29:1403-1413.
35. Davila-Roman VG, Vedala G, Herrero P, et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2002;40:271-277.
36. Neglia D, De Caterina A, Marraccini P, et al. Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. Am J Physiol Heart Circ Physiol. 2007;293: H3270YH3278.
37. Abraham D, Hofbauer R, Schäfer R, et al. Selective downregulation of VEGFA( 165), VEGF-R(1), and decreased capillary density in patients with dilative but not ischemic cardiomyopathy. Circ Res. 2000;87:644-647.
38. Mosseri M, Schaper J, Admon D, et al. Coronary capillaries in patients with congestive cardiomyopathy or angina pectoris with patent main coronary arteries. Ultrastructural morphometry of endomyocardial biopsy samples. Circulation. 1991;84:203-210.
39. Figulla HR, Vetterlein F, Glaubitz M, et al. Inhomogenous capillary flowand its prevention by verapamil and hydralazine in the cardiomyopathic Syrian hamster. Circulation. 1987;76:208-216.
40. Isobe S, Ando A, Nanasato M, et al. Combined study with FDG PET and Tl SPECT in patients with idiopathic dilated cardiomyopathy. Nucl Med Commun. 2003;24:1071-1080.
41. McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadoliniumenhanced cardiovascular magnetic resonance. Circulation. 2003;108:54-59.
42. Klein C, Nekolla SG, Bengel FM, et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002;105:162-167.
43. Figulla HR, Gietzen F, Zeymer U, et al. Diltiazem improves cardiac function and exercise capacity in patients with idiopathic dilated cardiomyopathy. Results of the Diltiazem in Dilated Cardiomyopathy Trial. Circulation. 1996; 94:346-352.
44. Hasegawa S, Kusuoka H, Maruyama K, et al. Myocardial positron emission computed tomographic images obtained with fluorine-18 fluoro-2-deoxyglucose predict the response of idiopathic dilated cardiomyopathy patients to beta-blockers. J Am Coll Cardiol. 2004;43:224-233.
45. Belonje AM, Voors AA, van Gilst WH, et al. Erythropoietin in chronic heart failure. Congest Heart Fail. 2007;13:289-292.
46. Chaowu Y, Li L, Shihua Z. Histopathological features of delayed enhancement cardiovascular magnetic resonance in isolated left ventricular noncompaction. J Am Coll Cardiol. 2011:311-312.